Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-intensity anticoagulation with HeartMate 3 LVAS
NCT03078374Unknown
- Sponsor
- Institute for Clinical and Experimental Medicine
- Start
- Jan 2017
- Primary completion
- Jan 2022
- Modality
- Small Molecules
01
Overview
Open-label trial of warfarin in heart failure (HF), sponsored by Institute for Clinical and Experimental Medicine. Primary endpoint: Survival-free rate of thromboembolic and hemorrhagic events at 12 months. Status: unknown.
02
Drugs
warfarin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03078374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03078374.